Table 1 Deaths from ruptured abdominal" aortic aneurysm by age, England and Wales 1992'
• The totals include 1271 deaths in men and 598 in women with site not specified as thoracic or abdominal (with site specified, 9% of deaths in men and 29% of deaths in women were certified as thoracic). The screening test The screening test is the measurement of the maximum aortic diameter using ultrasonography. The aorta can be visualised in 99% of cases and maximum aortic diameter can be measured accurately (based on comparisons with intraoperative and computed tomographic (CT) measurernentsj.P Theoretically, the identification of aortic aneurysms and measurement of their size might be more specific and precise than can be achieved by simply measuring the maximum aortic diameter,2l-25 because of the variation between people in the diameter of the normal aorta (1,4 to 3·0 cm in 401 men aged 65-74). 24 However, the maximum aortic diameter alone correlates fairly closely with the presence of an aneurysm, though uncertainty occurs in the range 2·5 to 3·0 ern (14% of all men aged 65-74). 24 Aortic diameters over 3·5 ern unequivocally indicate aneurysms, and rupture is rare in aneurysms less than 5 cm in diameter.
people aged 60 or over (table 1) , causing 1·9% of all deaths in men and 0·7% of all deaths in women over the age of 60. Death from ruptured aortic aneurysms may be undercertified as, without a necropsy, sudden unexpected death from a ruptured aneurysm might be miscertified as due to ischaemic heart disease. Table 2 shows the results of six studies that combined data from coroners' necropsies and hospital admissions to identify all cases of ruptured abdominal aneurysms in a defined population and assess the outcome. About a third of the patients died before reaching hospital and a further third died in hospital before surgery could be arranged. The operative mortality for acute surgical repair was about 50%, leaving an estimated survival rate of 18%.
For an aorta to rupture, an aneurysm must first form and grow to a critical size -analogous to a blowout in an inner tube. Table 3 lists .13 follow up studies recording the risk of rupture of aortic aneurysms according to maximum aortic diameter in patients who were observed without intervention (because the aneurysm was small, the patient declined surgery, the study was performed before the availability of surgery, or the risk of surgery was judged too high because of other illness). The probability of rupture increases with the size of the aneurysm. A logistic regression model fitted to the data yielded estimates of risk according to aortic diameter (table 4) . The estimated risk of rupture over one year increases from 0·4% for aneurysms of maximum aortic diameter 3·(}-3·9 ern to 24·5% for aneurysms 7·(}-7·9 cm.
Rare/l0 000
Epidemiology and natural history In England and Wales in 19924515 deaths in men and 1770 deaths in women were certified due to ruptured aneurysms of the abdominal aorta (or aorta, site unspecified, see table 1). Over 97% of the certified deaths from ruptured abdominal aortic aneurysms were in Aneurysms of the abdominal aorta are usually fatal when they rupture, but they can be detected non-invasively by ultrasonography and treated by elective surgery with an operative mortality of about 5 %.1 Screening programmes have been set up in some centres," but their value and cost effectiveness has been questioned. The main uncertainties are the risk of rupture without intervention and the reduced life expectancy after surgery due to the increased risk of other associated circulatory diseases. In this paper we report a quantitative analysis of the published evidence to estimate (a) the risk of rupture of abdominal aortic aneurysms according to size; (b) the life expectancy of patients with aortic aneurysms after surgery; and (c) the performance of screening. We also identify necessary research. Table 3 Results of studies estimating risk of death from rupture of abdominal aortic aneurysm according to size Measurement of maximum aortic diameter therefore constitutes the screening test. The general strategy in screening is to detect aneurysmal enlargement and monitor the rate of expansion but to delay intervention until the. risk of rupture is no longer negligible. Table 1 shows that abdominal ullrasonography can be limited to men aged 60 and over. In women the risk of death from ruptured aneurysm is lower, and age specific mortality corresponds with that in men 15 years younger. So if men of 60 and over were invited for an ultrasound examination the equivalent age group in women, on grounds of equity, would be those aged 75 and over.
Screening aims at identifying individuals with a sufficiently high risk of death from a ruptured aortic aneurysm to justify an elective insertion of a prosthetic aorta. This operation 
UNAFFECTED SUBJECTS
To obtain the distribution of maximum aortic diameter in subjects who do not have a ruptured abdominal aortic aneurysm ideally requires necropsy data analogous to that used above in subjects who do rupture an aneurysm. The necropsy studies were retrospective, however, and it is likely that small « 5 ern aortic diameter) unruptured aneurysms were unreported or unnoticed because the prevalence was low in comparison with an ultrasound survey.231 The necessary information can be
Estimating detection rates and false positive rates
To estimate detection rates and false positive rates requires knowledge of the distribution of maximum aortic diameter in subjects with (affected) and without (unaffected) a ruptured aortic aneurysm.
AFFECTED SUBJECTS
Estimates of the distribution of maximum aortic diameter in cases of ruptured abdominal aortic aneurysm are available from studies reporting the distribution in patients presenting for emergency surgery for acute rupture of the aneurysm (measuring aneurysmal diameter with callipers),' 27 28 and studies reporting measurements taken at necropsy in patients who died of acute rupture of the aneurysm." 30 Results were similar in three surgical studies and two necropsy studies; the mean aortic diameter in individuals with a ruptured aneurysm was about 8·5 ern in each type of study. Data from a third necropsy study" were not used as the elective resection of large aneurysms was common in the locality. Table 5 shows the distribution of aortic diameter in each of the five individual studies and the summary distribution, which was skewed to the right and not well fitted by any simple statistical function. From the cumulative percentage distribution (also shown in table 5), subtracted from 100%, plotted and smoothed (using cubic splines) the detection rate according to aortic diameter can be estimated (figure).
has a perioperative mortality of 5% or less, based on published series from specialist centres since 1980,115 18 and a long term mortality from infection of the prosthesis of about 1%. Only about a quarter of all abdominal aortic aneurysms ultimately rupture: they cause death in 1·9% of men but their prevalence in men aged 65-80 is 7'5%/ increasing from 5·9% at age 65 to 9·0% at age 75. 26 The "cut off" value of aortic diameter is selected so as to attain a high detection rate (the proportion of all persons who will rupture an abdominal aortic aneurysm and would be identified as screen positive), but also a low enough false positive rate (the proportion of all persons who will not have a ruptured abdominal aortic aneurysm but would be identified as screen positive and recommended elective surgery).
Duration of follow up (years)
3-3-9 4-4·9 5-5'9 Scot!' Table 7 summarises detection rates and false positive rates according to cut off level of aortic diameter. With a policy of offering surgery to all men with aortic aneurysms of diameter 6 em or greater, about 86% of all men who would rupture an aortic aneurysm could be identified and offered surgery (detection rate 86%) but only 0·6% of the men who would not have ruptured an aortic aneurysm would be offered surgery (false positive rate 0'6%). The ratio of the two, the likelihood ratio, is 143the relative risk in screen positive men compared with that in the general population, or the "concentrating power" of the screening test. Multiplying this by the mortality of 10·10 per 10 000 men aged 65-80 gives an estimate of the risk of rupture over the next year in screen positive men of 14% or about 1:7. The risk of rupture before death according to size can be estimated from the ratio of ruptured to unruptured aortic aneurysms in three necropsy studies 2 9-3 \ -94:66 (1'4:1) for aneurysms 7 em or greater, and about 1:1 for all aneurysms 6 em or greater.
Screening performance

Life expectancy of men with abdominal aortic aneurysms
There is concern that screening for abdominal aortic aneurysm may not be worthwhile because even after successful elective surgery such patients are prone to associated atherosclerotic diseases. They have increased mortality from heart disease, stroke, renal failure, and rupture of a second, thoracic, aortic aneurysm. This excess risk can be quantified using 15 American published case series, in which 484 deaths occurred from the above four causes and 281 deaths from all non-circulatory causes (excluding deaths from rupture of the abdominal aneurysm or surgery to remove it). II 1215272832-41 The ratio of the two, 484:281 or 1'72:1, compares with a ratio of 0,97:1 in the US general population at the time of the studies for people in the same age group. Patients with abdominal aortic aneurysms therefore have an excess risk of death from heart disease, stroke, renal failure, and ruptured thoracic aortic aneurysm in combination of about 77% 1'72/0·97 = 1'77). From 1992 England and Wales mortality data, the life expectancy of men was 17·7 years at age 60,14'1 years at age 65, 11·0 years at age 70, and 8·3 years at age 75.
Allowing for the increased risk shortens these life expectancies by about two years (15'4, 12'0, 9'1, and 6·7 years respectively). The average number of years of life lost by men who die from ruptured abdominal aortic aneurysms between the ages of 60 and 79 is 9·1 years. t Proportion of subjects without a ruptured adbominal aortic aneurysm with an aneurysmal diameter above the cut off. Cost-benefit analysis of screening Table 8 shows calculations of the financial costs and benefits of screening. The estimated total cost of screening and surgery for each life saved is £6787, and the cost for each year of life saved is £746. This is less than the cost of many preventive and therapeutic measures in common clinical practice. found to have aneurysms will require more frequent examinations; this is approximately balanced by the number of men without aneurysms who die before the second screening examination. With screening, an estimated 2040 men would require elective surgery. This is derived as follows. Of 100000 men aged 60, 1188 will die from a ruptured aortic aneurysm before the age of80 (obtained by applying the age specific death rates in table 1, allowing for the number of men who die from other causes before the age of 80 from 1992 England and Wales death rates'), With a cut off value for the maximum aortic diameter of 6 em, the detection rate is 86% (table 7) , so 102 (86% of 1188) men would have been screen positive. As discussed in the section on "Screening performance", the odds of eventually rupturing an aneurysm with a maximum aortic diameter of 6 em or more is 1: 1, so 2040 (1020 x 2) men would have elective surgery.
In the absence of screening 1020 men would die from ruptured aortic aneurysm, a further 220 would survive a rupture, and a total 1240 men would rupture an aneurysm (since 18% survive rupture (table  2) , 1020/(1-0'18) = 1240). Of these 1240 men, from the proportions in table 2, 447 (36%) would have emergency surgery and a further 335 (27%) would reach hospital alive but die before an operation could be arranged.
DERIVATION OF NUMBERS IN TABLE 8
Cost estimates published in 1990 were used." These were £4.60 for each ultrasound examination, £4000 for elective surgery, and £6000 for emergency surgery. A cost of £500 was assumed for failed hospital resuscitation in those who reached hospital alive but died before surgery.
An average of two examinations per man (at ages of, say, 60 and 70) was assumed. Men Screening policy and further research Men with abdominal aortic aneurysms 6 ern or more in diameter face a risk of rupture of the aneurysm estimated as 14% in the next year and a risk of at least half that the aneurysm will eventually kill them -risks that greatly exceed the 5% operative mortality for elective surgery. After surgery these men have a life expectancy similar to that of an average man two years older. Population screening saves lives and is cost effective. A national population screening programme should begin, based on age-sex population registers, with men aged 60 and over being sent letters of invitation to attend for screening, in the same way as the programme for screening for breast cancer in Britain and other countries operates.
There is no reason why screening should not begin immediately, without further research. Additional information is needed to specify the most cost effective service, but it could be obtained from an established screening programme. The additional information necessary falls into five categories:
Firstly, the best screening cut off level is not known. A level of 6 em is conservative, yielding a detection rate of about 86% and a false positive rate of about 0·5%. The screening programme will generate additional data on the "marginal" risk of rupture of aneurysms immediately below this value, allowing modification of the cut off point. Taking into account the difference between the infrarenal and suprarenal aortic diameter may yield more precise estimates of the risk of rupture." 25 Secondly, when the aortic diameter is below this cut off value the appropriate interval between examinations is not known. Table 9 shows the average aneurysmal expansion rates according to aortic diameter using data from seven studies. On average, an abdominal aortic aneurysm of diameter 3 ern would take four years to reach 4 ern in diameter, a further three years to reach 5 cm, and a further two years to reach 6 em (nine years in all). Individual rates vary and additional data would be needed to estimate the necessary follow up interval to detect, for example, 95% of all aneurysms at the time they reach an aortic diameter of 6 ern. Two routine screening examinations of the general population at the age of perhaps 60 and 70 years might be scheduled, with more frequent examinations of men with aortic diameter 3 em or greater (about 7% of men aged 60-79). The extra data would provide the necessary centile rates of aneurysmal growth so that the timing of the second visit could be determined by the diameter of the aorta at the first.
Thirdly, randornised trials are needed to investigate possible medical treatments to reduce the rate of expansion of small aneurysms. An observational study has suggested that Law, Morris, Wald blockers reduce the rate of aneurysmal expansion." Also, the risk of aortic aneurysms increases with blood pressure and serum low density lipoprotein cholesterol levels.Y'" Drug treatment to lower serum cholesterol and to lower blood pressure in all patients with aneurysms (not only those considered hypertensive) may both reduce the rate of expansion of aortic aneurysms. A factorial trial of medical treatment, with four randomised groups receiving cholesterol reduction, blood pressure reduction, both or neither would answer these questions. If such a trial had 50 patients in each of these four arms, the probability of detecting (P<0'05) a halving in the rate of expansion of an aneurysm 4--5 em in diameter would be 86% for either treatment alone and 58% for both treatments in combination.
Fourthly, the perioperative mortality of elective surgery may be reduced by more accurate identification of patients at high risk. A randomised trial of medical versus surgical treatment in patients at high risk may be appropriate. However, the likely availability in the next few years of endovascular prostheses (inserted through the femoral artery and likely to carry a low operative mortality) could reduce the risk of intervention in patients at high risk.
If trials of the endovascular prosthesis confirm a low operative mortality, intervention at a lower threshold of aortic diameter would be appropriate.
Conclusions
A national screening programme for abdominal aortic aneurysms should be established. A conservative screening cut off level of 6·0 em aortic diameter would identify 86% of all men who, in the absence of treatment, would die from ruptured aortic aneurysm, at a cost of 5% operative mortality and surgery on a similar number of men who would not have died from ruptured aortic aneurysm. The benefits greatly outweigh the costs, and a national screening programme could prevent the majority of deaths in men aged 60-80 -about 2500 deaths a year in England and Wales. Guirguis"
0·2' (108) 0·3' (73) 0·4' (21) 0·8'
All studies 0·14 (74) 0·25 (269) 0·36 (186) 0·49 (81) 0·70 (30) • Median PLH That is true, but the number of patients requiring further screening will be small and should not add appreciably to the costs.
Professor J Chamberlain, director, Institute of
Cancer Research
I was also interested in the frequency of screening because the costs you referred to were £Im for a single screen for 65 year aids, but there will be follow up costs that won't necessarily increase or reduce the cost per year of life saved but will increase the cost to the health service. ML This would be an effective approach. We would need to know not only the average growth rate but also the fastest growth rate, or the growth rate at, say, the 98th centile, to assess the appropriate interval to the next appointment. Large numbers would be needed to obtain the necessary data on the tail of a distribution of aneurysm growth rates. Those data would accumulate automatically in a large screening programme that started off with a reasonably short interval between screening but with reviews could be changed later.
* * *
Mr J Northover, colorectal surgeon, London I'm not yet convinced that there should be a national screening programme for aortic aneurysm. Someone with an aortic aneurysm, especially one that perforates, has other systems affected so they stand a good chance of dying from a stroke or heart attack fairly soon afterwards. To decide whether screening is effective we need to know not only the risk of perforation, or even the risk of dying from rupture, but also what is the risk of dying from other conditions fairly shortly afterwards.
PLH I think the question is based on a false assumption. The survival after surgery for aortic aneurysm, either ruptured or elective, is almost the same as that for a group of the same age who did not have this condition. For an aneurysm detected through a screening programme the extension to life is roughly 10 years, even for very elderly people.
Editorial comment Men with aortic aneurysms have an increased risk of ischaemic heart disease and other diseases that is equivalent to about a two year reduction in overall life expectancy. A man of 65 after surgery for an aortic aneurysm has the life expectancy of an average 67 year old man. Advice on lowering blood pressure and cholesterol and stopping smoking, if followed, will offset the increased risk of ischaemic heart disease in these men.
Mr Cam Donaldson, deputy director, Health Economics Research Unit
Dr Harris described a procedure in which a large Law, Morris, Wald number of people will be told that they have an aneurysm but that nothing will-be done'about it except to wait and see. Has there been any assessment of the psychological impact on those people, who will be a larger group than those at risk of serious rupture? Also, Dr Law suggested that If the distributions of affected and unaffected people overlapped greatly then a screening test was not worthwhile, but this is not necessarily the case. If the screening rest is very cheap and the proposed treatment is also very cheap then it still might be an efficient use of resources to proceed with the test.
ML If the proposed treatment is very cheap then there is surely no bar to giving it to the whole population. A test of poor discriminatory function should be abandoned, irrespective of economic considerations.
The possibility of inducing anxiety applies to all screening programmes. The screening test for aortic aneurysms is distinctive in that a negative result allows greater reassurance than a negative result for almost any other screening test.
Mr RAP Scott, consultant, Chichester -Are you saying there is no basis for doing a trial, or for introducing a screening programme and including a control group? ML There would be if there was an important question that such a trial would answer but I'm not aware that there is.
